Identification of a common mutation (Gly194Cys) in both Arab Moslem and Ashkenazi Jewish patients with dihydrolipoamide dehydrogenase (E3) deficiency: Possible beneficial effect of vitamin therapy

详细信息    查看全文

• 作者：Y. S. Hong ; S. H. Korman ; J. Lee ; P. Ghoshal ; Q. Wu ; V. Barash ; S. Kang ; S. Oh ; M. Kwon and A. Gutman ; et al.
• 刊名：Journal of Inherited Metabolic Disease
• 出版年：2003
• 出版时间：2003
• 年：2003
• 卷：26
• 期：8
• 页码：816-818
• 全文大小：46 KB

文摘

Summary: Dihydrolipoamide dehydrogenase (E3) deficiency with a clinical phenotype and genotype (Gly194Cys homozygous), previously identified only in Ashkenazi Jewish patients, was diagnosed in two Palestinian Arab siblings and two unrelated Ashkenazi Jewish patients. While three of the four patients died in childhood without specific treatment, the surviving patient at age 18 years may have benefited from long-term daily supplementation with a cocktail of riboflavin, biotin, coenzyme Q and carnitine.